Cargando…
BIO89-100 Demonstrated Robust Reductions in Liver Fat and Liver Fat Volume (LFV) by MRI-PDFF, Favorable Tolerability and Potential for Weekly (QW) or Every 2 Weeks (Q2W) Dosing in a Phase 1b/2a Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in NASH
Background: FGF21 is an endogenous hormone that regulates carbohydrate, lipid and energy metabolism. FGF21 analogs improve liver and metabolic abnormalities in non-alcoholic steatohepatitis (NASH). BIO89-100 is a long-acting glycoPEGylated FGF21, with promising tolerability and pharmacodynamic effec...
Autores principales: | Frias, Juan Pablo, Lawitz, Eric J, Ortiz-LaSanta, Grisell, Franey, Bridgette, Morrow, Linda, Chen, Chao-Yin, Tseng, Leo, Charlton, R William, Mansbach, Hank, Margalit, Maya, Loomba, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089146/ http://dx.doi.org/10.1210/jendso/bvab048.010 |
Ejemplares similares
-
Weight Loss Maintenance With Once-Weekly Semaglutide 2.4 MG in Adults With Overweight or Obesity Reaching Maintenance Dose (STEP 4)
por: Rubino, Domenica M, et al.
Publicado: (2021) -
Insulin Resistance Shows Stronger Correlation With Ectopic Liver Fat Instead of Visceral Fat in Asian Indians
por: Garg, Umesh Kumar, et al.
Publicado: (2021) -
Comparison of darbepoetin alfa dosed weekly (QW) vs. extended dosing schedule (EDS) in the treatment of anemia in patients receiving multicycle chemotherapy in a randomized, phase 2, open-label trial
por: Schwartzberg, Lee, et al.
Publicado: (2010) -
Liver PDFF estimation using a multi-decoder water-fat separation neural network with a reduced number of echoes
por: Meneses, Juan Pablo, et al.
Publicado: (2023) -
LBODP003 Effects Of 4-weeks’ Treatment With Intraperitoneal Colchicine On Metabolic And Inflammatory Outcomes In Mice Fed A High-fat Diet
por: Arner, Brooke E, et al.
Publicado: (2022)